Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 04-11-2022
A fair growth of 8.57% in the revenue at Rs. 41512.70 millions was reported in the September 2022 quarter as compared to Rs. 38234.50 millions during year-ago period.Net profit declined -7.93% to Rs. 7051.90 millions from Rs. 7659.50 millions.The company reported a degrowth in operating Profit to 11533.30 millions from 11586.10 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 41512.70 | 38234.50 | 8.57 | 73084.00 | 73341.20 | -0.35 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 922.80 | 1977.30 | -53.33 | 2099.60 | 2773.90 | -24.31 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 11533.30 | 11586.10 | -0.46 | 21283.90 | 23563.90 | -9.68 | 40331.70 | 32976.90 | 22.30 |
| Interest | 75.00 | 76.00 | -1.32 | 97.10 | 156.00 | -37.76 | 269.30 | 450.70 | -40.25 |
| PBDT | 11458.30 | 11510.10 | -0.45 | 21186.80 | 23407.90 | -9.49 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1760.10 | 1389.70 | 26.65 | 2834.70 | 2529.40 | 12.07 | 4600.10 | 4686.20 | -1.84 |
| PBT | 9698.20 | 10120.40 | -4.17 | 18352.10 | 20878.50 | -12.10 | 35462.30 | 27840.00 | 27.38 |
| TAX | 2646.30 | 2460.90 | 7.53 | 4860.20 | 5333.90 | -8.88 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | -6.00 | 30.20 | -119.87 | -118.50 | -59.10 | 100.51 | -304.00 | -169.20 | 79.67 |
| PAT | 7051.90 | 7659.50 | -7.93 | 13491.90 | 15544.60 | -13.21 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1614.00 | 1613.30 | 0.04 | 1614.00 | 1613.30 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 27.78 | 30.30 | -8.32 | 29.12 | 32.13 | -9.36 | 30.81 | 29.18 | 5.59 |